Dublin, Feb. 07, 2023 (GLOBE NEWSWIRE) -- The "Cellular Health Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Cellular Health Testing Market to Reach $5.8 Billion by 2030
The global market for Cellular Health Testing estimated at US$3 Billion in the year 2022, is projected to reach a revised size of US$5.8 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2022-2030.
Single-Test Panels, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$3.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Multi-Test Panels segment is readjusted to a revised 10.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $880.9 Million, While China is Forecast to Grow at 8.1% CAGR
The Cellular Health Testing market in the U.S. is estimated at US$880.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2030 trailing a CAGR of 8.1% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.7% and 7.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.
Looking Ahead to 2023
Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.
Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Metrics
| Report Attribute | Details |
| No. of Pages | 184 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $3 Billion |
| Forecasted Market Value (USD) by 2030 | $5.8 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Cellular Health Testing - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Cellular Health Testing - Revolutionary Technology Provides Overview of Health at Cellular Level
- North America Projected to Retain Maximum Share in the Market
MARKET TRENDS & DRIVERS
- Rising Demand for Accurate Telomere Length Test Steers Market Growth
- Digital Transformation in Healthcare to Offer Significant Market Gains
- Focus on Healthy Life Expectancy (HLE) as a Measure of Population Health Promise Growth Opportunities
- Cellular Approach to Tackle Chronic Diseases Ensure Steady Growth Prospects
- Continuous Rise in Geriatric Population Throws Focus on Cellular Heath Screening
- Percentage (In %) of Global Population Aged 65 and Above by Region
- Government Policies and Measures Promoting Preventative Healthcare Augurs Well
- Personalized and Precision Medicine Presents Application Opportunities for Cellular Health Screening
- Growing Popularity of Direct-To-Consumer Approach to Testing Drives Market Demand
- Key Challenges
- Limited Reimbursement
- Challenges in Sample Transportation
- Variation in Pricing of Test Kits
- Covid-19 Impact on Cellular Health Testing Market
FOCUS ON SELECT PLAYERS (Total 22 Featured)
- Bio-Reference Laboratories, Inc.
- Cell Science Systems Corp.
- Cleveland Heartlab, Inc.
- Dna Labs India
- Genova Diagnostics
- Immundiagnostik AG
- Laboratory Corporation of America Holdings
- Life Length
- Quest Diagnostics, Inc.
- Repeat Diagnostics Inc. (Repeat Dx)
- Segterra, Inc.
- SpectraCell Laboratories, Inc.
- Telomere Diagnostics, Inc. (Tdx)
- Zimetry LLC
For more information about this report visit https://www.researchandmarkets.com/r/89shyn-health?w=12
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
